PMID- 28911256 OWN - NLM STAT- MEDLINE DCOM- 20180905 LR - 20180921 IS - 2325-9582 (Electronic) IS - 2325-9574 (Linking) VI - 16 IP - 6 DP - 2017 Nov/Dec TI - Immune Reconstitution Inflammatory Syndrome in Patients with AIDS and Disseminated Coccidioidomycosis: A Case Series and Review of the Literature. PG - 540-545 LID - 10.1177/2325957417729751 [doi] AB - Coccidioidomycosis causes substantial morbidity and mortality in endemic areas, and dissemination is frequent in patients with impaired cellular immunity such as AIDS. Immune reconstitution inflammatory syndrome (IRIS) is paradoxical clinical worsening after initiation of antiretroviral therapy (ART) in a patient with HIV and a simultaneous opportunistic infection (OI). Immune reconstitution inflammatory syndrome has been well described for a host of mycobacterial, viral, and fungal OIs and malignancies such as Kaposi sarcoma. To date, only 3 cases of IRIS due to coccidioidomycosis have been reported in the literature. At our institution, we report 4 cases of IRIS in HIV-infected patients with disseminated coccidioidomycosis. Unfortunately, all 4 patients died of worsening coccidioidal infection after initiating ART. The optimal timing of ART in patients with AIDS and coccidioidomycosis remains to be elucidated. FAU - Mu, Anandit AU - Mu A AD - 1 Division of Infectious Diseases, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA. FAU - Shein, Thwe Thwe AU - Shein TT AD - 1 Division of Infectious Diseases, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA. FAU - Jayachandran, Priya AU - Jayachandran P AD - 2 Department of Medicine, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA. FAU - Paul, Simon AU - Paul S AD - 1 Division of Infectious Diseases, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA. AD - 2 Department of Medicine, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA. LA - eng PT - Case Reports PT - Journal Article PT - Review DEP - 20170914 PL - United States TA - J Int Assoc Provid AIDS Care JT - Journal of the International Association of Providers of AIDS Care JID - 101603896 RN - 0 (Anti-HIV Agents) RN - 0 (Antifungal Agents) RN - 0 (liposomal amphotericin B) RN - 7XU7A7DROE (Amphotericin B) RN - 8VZV102JFY (Fluconazole) SB - IM MH - AIDS-Related Opportunistic Infections/*drug therapy/etiology MH - Abscess/drug therapy/etiology MH - Acquired Immunodeficiency Syndrome/complications/*drug therapy MH - Adult MH - Amphotericin B/*therapeutic use MH - Anti-HIV Agents/*adverse effects MH - Antifungal Agents/therapeutic use MH - Brain/diagnostic imaging MH - Central Nervous System Fungal Infections/diagnostic imaging MH - Coccidioidomycosis/*drug therapy/etiology MH - Fatal Outcome MH - Female MH - Fluconazole/therapeutic use MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/*chemically induced MH - Liver/pathology MH - Magnetic Resonance Imaging MH - Male OTO - NOTNLM OT - HIV/AIDS OT - antiretroviral therapy OT - coccidioidomycosis OT - immune reconstitution inflammatory syndrome EDAT- 2017/09/16 06:00 MHDA- 2018/09/06 06:00 CRDT- 2017/09/16 06:00 PHST- 2017/09/16 06:00 [pubmed] PHST- 2018/09/06 06:00 [medline] PHST- 2017/09/16 06:00 [entrez] AID - 10.1177/2325957417729751 [doi] PST - ppublish SO - J Int Assoc Provid AIDS Care. 2017 Nov/Dec;16(6):540-545. doi: 10.1177/2325957417729751. Epub 2017 Sep 14.